Search of: DLBCL | radioimmunotherapy - List Results

Found 9 studies with search of:

DLBCL | radioimmunotherapy

Rank

Status

Study

1

Withdrawn

Conditions:	AIDS-Related Lymphoma; Adult Non-Hodgkin's Lymphoma; Anaplastic Large Cell Lymphoma
Interventions:	Drug: cisplatin; Drug: cytarabine; Drug: etoposide; Drug: methylprednisolone; Drug: rituximab; Drug: yttrium Y 90 ibritumomab tiuxetan; Procedure: antibody therapy; Procedure: biological therapy; Procedure: chemotherapy; Procedure: monoclonal antibody therapy; Procedure: radiation therapy; Procedure: radioimmunotherapy; Procedure: radioisotope therapy

2

Recruiting

Condition:	B-Cell Lymphoma
Intervention:	Drug: 90Y-DOTA-hLL2

3

Recruiting

Condition:	Lymphoma
Interventions:	Biological: rituximab; Procedure: computed tomography; Procedure: positron emission tomography; Procedure: radionuclide imaging; Procedure: single photon emission computed tomography; Radiation: tositumomab and iodine I 131 tositumomab; Radiation: yttrium Y 90 ibritumomab tiuxetan

4

Active, not recruiting

Conditions:	Leukemia; Lymphoma
Interventions:	Radiation: indium In 111 LL2 IgG; Radiation: yttrium Y 90 epratuzumab

5

Completed

Conditions:	Lymphoma; Lymphoproliferative Disorder
Interventions:	Biological: rituximab; Radiation: yttrium Y 90 ibritumomab tiuxetan

6

Active, not recruiting

Condition:	Lymphoma
Interventions:	Biological: monoclonal antibody Lym-1; Drug: cyclosporine; Drug: paclitaxel; Radiation: indium In 111 monoclonal antibody Lym-1; Radiation: yttrium Y 90 monoclonal antibody Lym-1

7

Active, not recruiting

Condition:	Lymphoma
Interventions:	Biological: rituximab; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: prednisone; Drug: vincristine sulfate; Radiation: radiation therapy; Radiation: yttrium Y 90 ibritumomab tiuxetan

8

Active, not recruiting

Conditions:	Leukemia; Lymphoma
Interventions:	Biological: filgrastim; Procedure: autologous bone marrow transplantation; Procedure: peripheral blood stem cell transplantation; Radiation: indium In 111 monoclonal antibody MN-14; Radiation: yttrium Y 90 epratuzumab

9

Recruiting

Condition:	Lymphoma
Interventions:	Biological: rituximab; Drug: agatolimod sodium; Other: biomarker analysis; Other: flow cytometry; Other: immunologic technique; Other: laboratory biomarker analysis; Procedure: radionuclide imaging; Procedure: single photon emission computed tomography; Radiation: indium In 111 ibritumomab tiuxetan; Radiation: yttrium Y 90 ibritumomab tiuxetan

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.

RSS Feeds for studies found by your search that were: